Currently holds a position at Tricida Inc
Position | Company | Period |
---|---|---|
Independent Director | Tricida Inc | Jan. 1, 2014 - |
Independent Director | SI-BONE Inc | April 1, 2014 - June 13, 2019 |
Independent Director | Loxo Oncology Inc | Sept. 1, 2013 - Dec. 22, 2017 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-05-24 | 2023-05-22 |
Prelude Therapeutics Inc
(PRLD)
|
B Purchase |
869,565
+9.4%
5.754,999,999 USD |
869,565 +9.4% | 5.75 | 4,999,999 USD | |
2022-11-25 | 2022-11-25 |
Tricida Inc
(TCDA)
|
S Sale |
3,629,226
-100.0%
0.22798,430 USD |
3,629,226 -100.0% | 0.22 | 798,430 USD | |
2022-11-25 | 2022-11-23 |
Tricida Inc
(TCDA)
|
S Sale |
5,617,300
-60.8%
0.211,179,633 USD |
5,617,300 -60.8% | 0.21 | 1,179,633 USD | |
2022-11-25 | 2022-11-22 |
Tricida Inc
(TCDA)
|
S Sale |
1,034,421
-10.1%
0.22227,573 USD |
1,034,421 -10.1% | 0.22 | 227,573 USD | |
2022-09-21 | 2022-09-19 |
Third Harmonic Bio Inc
(THRD)
|
B Purchase |
300,000
+5.5%
17.005,100,000 USD |
300,000 +5.5% | 17.00 | 5,100,000 USD | |
2021-08-30 | 2021-08-30 |
Repare Therapeutics Inc
(RPTX)
|
PS Planned sale |
197
-0.2%
33.926,682 USD |
197 -0.2% | 33.92 | 6,682 USD | |
2021-08-30 | 2021-08-30 |
Repare Therapeutics Inc
(RPTX)
|
PS Planned sale |
6,500
-0.2%
33.92220,480 USD |
6,500 -0.2% | 33.92 | 220,480 USD | |
2021-08-30 | 2021-08-27 |
Repare Therapeutics Inc
(RPTX)
|
PS Planned sale |
209
-0.2%
33.947,093 USD |
209 -0.2% | 33.94 | 7,093 USD | |
2021-08-30 | 2021-08-27 |
Repare Therapeutics Inc
(RPTX)
|
PS Planned sale |
6,884
-0.2%
33.94233,643 USD |
6,884 -0.2% | 33.94 | 233,643 USD | |
2021-08-30 | 2021-08-26 |
Repare Therapeutics Inc
(RPTX)
|
PS Planned sale |
126
-0.1%
34.524,350 USD |
126 -0.1% | 34.52 | 4,350 USD | |
2021-08-30 | 2021-08-26 |
Repare Therapeutics Inc
(RPTX)
|
PS Planned sale |
4,157
-0.1%
34.52143,500 USD |
4,157 -0.1% | 34.52 | 143,500 USD | |
2021-08-25 | 2021-08-25 |
Repare Therapeutics Inc
(RPTX)
|
PS Planned sale |
208
-0.2%
34.347,143 USD |
208 -0.2% | 34.34 | 7,143 USD | |
2021-08-25 | 2021-08-25 |
Repare Therapeutics Inc
(RPTX)
|
PS Planned sale |
6,874
-0.2%
34.34236,053 USD |
6,874 -0.2% | 34.34 | 236,053 USD | |
2021-08-25 | 2021-08-24 |
Repare Therapeutics Inc
(RPTX)
|
PS Planned sale |
119
-0.1%
34.074,054 USD |
119 -0.1% | 34.07 | 4,054 USD | |
2021-08-25 | 2021-08-24 |
Repare Therapeutics Inc
(RPTX)
|
PS Planned sale |
3,920
-0.1%
34.07133,554 USD |
3,920 -0.1% | 34.07 | 133,554 USD | |
2021-08-25 | 2021-08-23 |
Repare Therapeutics Inc
(RPTX)
|
PS Planned sale |
209
-0.2%
34.067,119 USD |
209 -0.2% | 34.06 | 7,119 USD | |
2021-08-25 | 2021-08-23 |
Repare Therapeutics Inc
(RPTX)
|
PS Planned sale |
6,885
-0.2%
34.06234,503 USD |
6,885 -0.2% | 34.06 | 234,503 USD | |
2021-04-01 | 2021-03-30 |
Ikena Oncology Inc
(IKNA)
|
B Purchase |
48,400
+70.2%
16.00774,400 USD |
48,400 +70.2% | 16.00 | 774,400 USD | |
2021-04-01 | 2021-03-30 |
Ikena Oncology Inc
(IKNA)
|
B Purchase |
375,000
+20.6%
16.006,000,000 USD |
375,000 +20.6% | 16.00 | 6,000,000 USD | |
2020-08-12 | 2020-08-10 |
Acutus Medical Inc
(AFIB)
|
B Purchase |
41,500
+inf%
18.00747,000 USD |
41,500 +inf% | 18.00 | 747,000 USD | |
2020-08-12 | 2020-08-10 |
Acutus Medical Inc
(AFIB)
|
B Purchase |
373,500
+inf%
18.006,723,000 USD |
373,500 +inf% | 18.00 | 6,723,000 USD | |
2020-06-25 | 2020-06-23 |
Repare Therapeutics Inc
(RPTX)
|
B Purchase |
99,200
+inf%
20.001,984,000 USD |
99,200 +inf% | 20.00 | 1,984,000 USD | |
2020-06-25 | 2020-06-23 |
Repare Therapeutics Inc
(RPTX)
|
B Purchase |
675,000
+25.9%
20.0013,500,000 USD |
675,000 +25.9% | 20.00 | 13,500,000 USD | |
2020-03-16 | 2020-03-12 |
Imara Inc
(IMRA)
|
B Purchase |
937,500
+inf%
16.0015,000,000 USD |
937,500 +inf% | 16.00 | 15,000,000 USD | |
2019-04-05 | 2019-04-03 |
Tricida Inc
(TCDA)
|
B Purchase |
225,000
+2.1%
36.008,100,000 USD |
225,000 +2.1% | 36.00 | 8,100,000 USD |